Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I

Srđan Verstovšek, H. Kantarjian, Murat O. Arcasoy et al.|Haematologica|2013

Cited by 162